Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares
(NQ:
LSE
)
4.800
-0.200 (-4.00%)
Streaming Delayed Price
Updated: 3:53 PM EDT, Apr 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares
< Previous
1
2
3
4
5
6
7
Next >
Alpha FMC appoints new Senior Partner to lead global SimCorp partnership
Today 8:03 EDT
From
Alpha FMC
Via
GlobeNewswire
The 2026 Insurance Outlook – Alpha FMC Research Shows Industry Moves from Tech Modernisation to Measurable Performance
April 15, 2026
From
Alpha FMC
Via
GlobeNewswire
OTC Markets Group Welcomes EnSilica PLC to OTCQX
April 15, 2026
From
OTC Markets
Via
GlobeNewswire
Sintana Energy to Present at the Oil & Gas Virtual Investor Conference April 16th
April 14, 2026
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
The 2026 Asset & Wealth Management and Alternatives Outlooks
April 14, 2026
Alpha FMC Research Shows Shift in Focus from Innovation to Execution
From
Alpha FMC
Via
GlobeNewswire
Avacta CEO Christina Coughlin Named as One of In Vivo's 2026 Rising Leaders
April 14, 2026
From
Avacta Group PLC
Via
GlobeNewswire
88 Energy to Present at the Oil & Gas Virtual Investor Conference April 16th
April 13, 2026
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Alpha FMC to acquire JPSB
April 13, 2026
From
Alpha FMC
Via
GlobeNewswire
Leishen Energy Reaffirms Middle East Market Commitment; Saudi Production Facility Progressing Amid Regional Challenges
April 13, 2026
From
Leishen Energy Holding Co., Ltd.
Via
GlobeNewswire
HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2026
April 08, 2026
From
HUTCHMED (China) Limited
Via
GlobeNewswire
Avacta announces first patient treated in Phase 1 FOCUS-01 trial of FAP-Exd (AVA6103) - a sustained-release pre|CISION® exatecan peptide drug conjugate
March 31, 2026
From
Avacta Group PLC
Via
GlobeNewswire
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics
March 26, 2026
Next-generation therapeutic cancer vaccines in development for various oncology indications sold to NeoTrail Therapeutics
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
PPHC Added to Russell 2000® and Russell 3000® Indexes
March 24, 2026
From
Public Policy Holding Company, Inc.
Via
GlobeNewswire
Public Policy Holding Company, Inc. Announces Full Year 2025 Financial Results
March 23, 2026
From
Public Policy Holding Company, Inc.
Via
GlobeNewswire
PPHC Announces Acquisition of WPI Strategy
March 23, 2026
From
Public Policy Holding Company, Inc.
Via
GlobeNewswire
HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China
March 22, 2026
From
HUTCHMED (China) Limited
Via
GlobeNewswire
PPHC Expands Strategic Advisory Platform with Appointment of TrailRunner Sports President
March 18, 2026
From
Public Policy Holding Company, Inc.
Via
GlobeNewswire
Avacta Announces Preclinical and Translational Presentations of pre|CISION® Platform Candidates at the 2026 AACR Annual Conference
March 17, 2026
From
Avacta Group PLC
Via
GlobeNewswire
HUTCHMED Announces Update on Licensed Oncology Product TAZVERIK® in China
March 09, 2026
From
HUTCHMED (China) Limited
Via
GlobeNewswire
Intended Retirement of Independent Non-executive Director and changes of composition of board committees
March 06, 2026
From
HUTCHMED (China) Limited
Via
GlobeNewswire
PPHC To Report Fourth Quarter and Full Year 2025 Financial Results on March 23, 2026
March 05, 2026
From
Public Policy Holding Company, Inc.
Via
GlobeNewswire
HUTCHMED Reports 2025 Full Year Results and Business Updates
March 05, 2026
From
HUTCHMED (China) Limited
Via
GlobeNewswire
HUTCHMED Initiates Global Trial of PI3K/PIKK-EGFR ATTC Candidate HMPL-A580 in Patients with Solid Tumors
March 04, 2026
From
HUTCHMED (China) Limited
Via
GlobeNewswire
Avacta's pre|CISION Mechanism for Payload Delivery Shows Key Advantages Compared to an Antibody Drug Conjugate in Innovative AI-Driven Analysis
February 24, 2026
From
Avacta Group PLC
Via
GlobeNewswire
Leishen Energy Holding Co., Ltd. Announced Fiscal Year 2025 Financial Results Highlighting Strong Operating Cash Flow and Low Financial Leverage
February 15, 2026
From
Leishen Energy Holding Co., Ltd.
Via
GlobeNewswire
Corero Network Security to Present at the AI & Technology Virtual Investor Conference February 19th
February 13, 2026
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Avacta appoints Francis Wilson as Chief Scientific Officer
February 09, 2026
From
Avacta Group PLC
Via
GlobeNewswire
HUTCHMED to Announce 2025 Final Results
February 06, 2026
From
HUTCHMED (China) Limited
Via
GlobeNewswire
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics
February 03, 2026
Next-generation therapeutic cancer vaccines in development for various oncology indications sold to NeoTrail Therapeutics with an undisclosed purchase price
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program
February 03, 2026
Cardiac dosing limit removed and path forward to dose selection identified
From
AVACTA GROUP PLC
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
